India

Covaxin EUL WHO review process bharat biotech covid vaccine emergency use listing


Image Source : PTI

All documents required for Emergency Use Listing (EUL) have been submitted to WHO by Bharat Biotech for COVID-19 vaccine Covaxin as of July 9 and the review process by the agency has commenced, Minister of State for Health Bharati Pravin Pawar told Rajya Sabha on Tuesday.

Bharat Biotech has submitted all documents required for its COVID-19 vaccine Covaxin’s Emergency Use Listing (EUL) to the World Health Organisation (WHO) as of July 9 and the review process by the agency has commenced, Minister of State for Health Bharati Pravin Pawar informed Rajya Sabha on Tuesday.

Responding to a question on whether it has come to the notice of the government that Covaxin used in India is not recognised by many countries, Pawar said the government is aware that Covaxin at present is not part of WHO Emergency Use Listing (EUL).

Elaborating on efforts that have been made by the government to resolve this issue, Pawar said, “All documents required for Emergency Use Listing (EUL) have been submitted by Bharat Biotech International Ltd. to WHO as of 9th July 2021.”

The review process by WHO has commenced which usually takes up to six weeks to decide on Emergency Use Listing (EUL) submissions, she said in a written reply.

(With PTI Inputs)

ALSO READ | Bharat Biotech’s Covaxin trials for children underway; results expected by Sept: AIIMS chief

ALSO READ | Decision on Emergency Use Listing of Covaxin likely in August first week: WHO

Latest India News





Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button